(Q77359737)

English

Thrombospondin-1, vascular endothelial growth factor and fibroblast growth factor-2 are key functional regulators of angiogenesis in the prostate

scientific article published on 01 December 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11746276%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Thrombospondin-1, vascular endothelial growth factor and fibroblast growth factor-2 are key functional regulators of angiogenesis in the prostate (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11746276%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

author name string

J A Doll

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11746276%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

F K Reiher

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11746276%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

S E Crawford

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11746276%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

M R Pins

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11746276%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

S C Campbell

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11746276%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

N P Bouck

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11746276%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

publication date

1 December 2001

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11746276%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11746276%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

49

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11746276%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11746276%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

293-305

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11746276%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Evidence of independent origin of multiple tumors from patients with prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10025

21 January 2018

Transplacental carcinogenesis by stilbestrol

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10025

21 January 2018

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10025

21 January 2018

Topography of neovascularity in human prostate carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10025

21 January 2018

An analysis of microvessel density, androgen receptor, p53 and HER-2/neu expression and Gleason score in prostate cancer . preliminary results and therapeutic implications.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10025

21 January 2018

Cathepsin B in angiogenesis of human prostate: an immunohistochemical and immunoelectron microscopic analysis

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10025

21 January 2018

Optimized microvessel density analysis improves prediction of cancer stage from prostate needle biopsies

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10025

21 January 2018

Vascular density is a predictor of cancer-specific survival in prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10025

21 January 2018

Tumor angiogenesis correlates with progression after radical prostatectomy but not with pathologic stage in Gleason sum 5 to 7 adenocarcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10025

21 January 2018

Microvessel density predicts survival in prostate cancer patients subjected to watchful waiting

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10025

21 January 2018

Tumor angiogenesis is associated with progression after radical prostatectomy in pT2/pT3 prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10025

21 January 2018

Pigment epithelium-derived factor: a potent inhibitor of angiogenesis

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10025

21 January 2018

Expression of multiple angiogenic cytokines in cultured normal human prostate epithelial cells: predominance of vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10025

21 January 2018

Growth factors and epithelial-stromal interactions in prostate cancer development

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10025

21 January 2018

Vascular endothelial growth factor (VEGF) expression in prostate cancer and benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10025

21 January 2018

Vascular endothelial growth factor (VEGF) expression in prostatic tumours and its relationship to neuroendocrine cells

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10025

21 January 2018

Vascular endothelial growth factor expression and capillary architecture in high-grade PIN and prostate cancer in untreated and androgen-ablated patients

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10025

21 January 2018

VEGF overexpression in clinically localized prostate tumors and neuropilin-1 overexpression in metastatic forms

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10025

21 January 2018

Testosterone induces vascular endothelial growth factor synthesis in the ventral prostate in castrated rats

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10025

21 January 2018

Endothelial cell death, angiogenesis, and microvascular function after castration in an androgen-dependent tumor: role of vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10025

21 January 2018

Vascular endothelial growth factor expression and tumor angiogenesis are regulated by androgens in hormone responsive human prostate carcinoma: evidence for androgen dependent destabilization of vascular endothelial growth factor transcripts

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10025

21 January 2018

Neutralizing anti-vascular endothelial growth factor antibody completely inhibits angiogenesis and growth of human prostate carcinoma micro tumors in vivo

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10025

21 January 2018

FGF7 and FGF2 are increased in benign prostatic hyperplasia and are associated with increased proliferation

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10025

21 January 2018

Angiogenesis and prostate cancer: in vivo and in vitro expression of angiogenesis factors by prostate cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10025

21 January 2018

Distinct CXC chemokines mediate tumorigenicity of prostate cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10025

21 January 2018

Immunolocalization of the keratinocyte growth factor in benign and neoplastic human prostate and its relation to androgen receptor

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10025

21 January 2018

Association of transforming growth factor-beta 1 with prostate cancer: an immunohistochemical study

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10025

21 January 2018

Transforming growth factor beta1 is associated with angiogenesis, metastasis, and poor clinical outcome in prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10025

21 January 2018

A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10025

21 January 2018

Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10025

21 January 2018

Inactivation of the PTEN tumor suppressor gene is associated with increased angiogenesis in clinically localized prostate carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10025

21 January 2018

Thrombospondin-1 is a major activator of TGF-beta1 in vivo

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10025

21 January 2018

Transforming growth factor-beta complexes with thrombospondin

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10025

21 January 2018

Extracellular matrix-associated transforming growth factor-beta: role in cancer cell growth and invasion.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10025

21 January 2018

Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10025

21 January 2018

The p53 tumor suppressor gene inhibits angiogenesis by stimulating the production of thrombospondin.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10025

21 January 2018

Influence of tumour size on human prostate tumour metastasis in athymic nude mice

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10025

21 January 2018

A human fibrosarcoma inhibits systemic angiogenesis and the growth of experimental metastases via thrombospondin-1.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10025

21 January 2018

Assay and purification of naturally occurring inhibitor of angiogenesis

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10025

21 January 2018

Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10025

21 January 2018

Sequential development of an angiogenic phenotype by human fibroblasts progressing to tumorigenicity

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10025

21 January 2018

Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10025

21 January 2018

Fibroblast growth factor-2 (FGF-2) induces vascular endothelial growth factor (VEGF) expression in the endothelial cells of forming capillaries: an autocrine mechanism contributing to angiogenesis

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10025

21 January 2018

Methylation and silencing of the Thrombospondin-1 promoter in human cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10025

21 January 2018

Changes in growth factor expression in the ageing prostate may disrupt epithelial-stromal homeostasis

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10025

21 January 2018

Endothelial cell proliferation activity in benign prostatic hyperplasia and prostate cancer: an in vitro model for assessment

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10025

21 January 2018

Tumor induction of VEGF promoter activity in stromal cells

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10025

21 January 2018

What might a stromal response mean to prostate cancer progression?

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10025

21 January 2018

The application of an anti-angiogenic gene (thrombospondin-1) in the treatment of human prostate cancer xenografts

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10025

21 January 2018

Identifiers

10.1002/PROS.10025

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11746276%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11746276%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q77359737&oldid=2046654503"